These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 2811498)

  • 1. [Beneficial effect of 1,25-dihydroxyvitamin D3 in the treatment of myelofibrosis].
    Palomera L; García Díez I; Martínez R
    Med Clin (Barc); 1989 Sep; 93(7):265-8. PubMed ID: 2811498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Beta-thromboglobulin and platelet factor 4 in a follow-up of acute myelofibrosis (megakaryoblastic leukemia)].
    Palomera Bernal L; García Díez I
    Med Clin (Barc); 1990 Jun; 95(1):21-4. PubMed ID: 2146451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The beneficial effect of 1,25-dihydroxycholecalciferol on the excess of blasts and the myelofibrosis in 2 cases of chronic myeloproliferative syndrome].
    Raya Sánchez JM; Hernández Nieto L; Brito Barroso ML; Hernández García MT
    Med Clin (Barc); 1994 Mar; 102(10):380-2. PubMed ID: 8182985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1,25-Dihydroxyvitamin D3 in the treatment of idiopathic thrombocythemia and myelofibrosis.
    Foa P; Maiolo AT; Cortellaro M; Ortolani S; Pogliani E; Deliliers GL; Iurlo A; Zocchi L; Gualdoni A; Polli E
    Haematologica; 1990; 75(3):294-5. PubMed ID: 2227630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imatinib mesylate in idiopathic and postpolycythemic myelofibrosis.
    Hasselbalch HC; Bjerrum OW; Jensen BA; Clausen NT; Hansen PB; Birgens H; Therkildsen MH; Ralfkiaer E
    Am J Hematol; 2003 Dec; 74(4):238-42. PubMed ID: 14635203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Is 1,25(OH)2D3 effective in chronic osteomyelofibrosis?].
    Eugster C; Brun del Re GP; Bucher U
    Schweiz Med Wochenschr; 1986 Dec; 116(50):1767-70. PubMed ID: 3798067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathophysiological mechanisms operating in the development of myelofibrosis: role of megakaryocytes.
    Castro-Malaspina H; Moore MA
    Nouv Rev Fr Hematol (1978); 1982; 24(4):221-6. PubMed ID: 6292827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Megakaryoblastic leukemia (acute myelofibrosis): complete remission of a case with low-dose cytosine arabinoside].
    Palomera L; García Díez I; Woessner S; Velasco F; Torres A
    Sangre (Barc); 1988 Jun; 33(3):232-7. PubMed ID: 3175820
    [No Abstract]   [Full Text] [Related]  

  • 9. Acute myelofibrosis--a leukemia of pluripotent stem cell. A report of three cases and review of the literature.
    Amberger DM; Saleem A; Kemp BL; Truong LD
    Ann Clin Lab Sci; 1990; 20(6):409-14. PubMed ID: 2073090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenesis of myelofibrosis: role of ineffective megakaryopoiesis and megakaryocyte components.
    Castro-Malaspina H
    Prog Clin Biol Res; 1984; 154():427-54. PubMed ID: 6089232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathological features of acute megakaryoblastic leukaemia: Relationship between fibrosis and platelet-derived growth factor.
    Niino D; Tsuchiya T; Tomonaga M; Miyazaki Y; Ohshima K
    Pathol Int; 2013 Mar; 63(3):141-9. PubMed ID: 23530558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant expression of platelet-derived growth factor (PDGF) and PDGF receptor-alpha is associated with advanced bone marrow fibrosis in idiopathic myelofibrosis.
    Bock O; Loch G; Büsche G; von Wasielewski R; Schlué J; Kreipe H
    Haematologica; 2005 Jan; 90(1):133-4. PubMed ID: 15642683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Acute malignant myelofibrosis. Report of 3 cases].
    Joundi A; Caulet T; Caulet S; Patey M; Pluot M; Blaise AM
    Arch Anat Cytol Pathol; 1991; 39(3):103-8. PubMed ID: 1929569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extensive myelofibrosis responsive to treatment for acute erythroblastic leukaemia.
    Fadilah SA; Raja-Zahratul-Azma RS; Leong CF
    Malays J Pathol; 2006 Jun; 28(1):55-8. PubMed ID: 17694960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1-25 (OH)2 D3 in idiopathic myelofibrosis: a preliminary report.
    Petrini M; Cecconi N; Ambrogi F; Grassi B
    Haematologica; 1987; 72(6):567-9. PubMed ID: 3126118
    [No Abstract]   [Full Text] [Related]  

  • 16. [Acute myelofibrosis: apropos of a case with immunocytochemical and ultrastructural studies].
    Ocaña I; Alegre J; Fernández de Sevilla T; Ruiz Marcellán L; Ribera E; Martínez Vázquez JM
    Med Clin (Barc); 1989 Jan; 92(3):102-3. PubMed ID: 2496279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [TGF-beta and platelet].
    Kogawa K; Mogi Y; Morii K; Takimoto R; Niitsu Y
    Rinsho Ketsueki; 1994 Apr; 35(4):370-5. PubMed ID: 8028182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative and functional studies of impaired natural killer (NK) cells in patients with myelofibrosis, essential thrombocythemia, and polycythemia vera. I. A potential role for platelet-derived growth factor in defective NK cytotoxicity.
    Gersuk GM; Carmel R; Pattamakom S; Challita PM; Rabinowitz AP; Pattengale PK
    Nat Immun; 1993; 12(3):136-51. PubMed ID: 8329837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Myelofibrosis in patients with chronic myeloid leukemia treated with interferon-alpha].
    Kumas Sotiris ; Semenova EA; Turkina AG; Zakharova AV; Domracheva EV; Khoroshko ND; Frank GA
    Arkh Patol; 2003; 65(4):9-12. PubMed ID: 14518186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple myeloma with bone marrow biopsy features simulating concomitant chronic idiopathic myelofibrosis.
    Schmidt U; Ruwe M; Leder LD
    Nouv Rev Fr Hematol (1978); 1995; 37(2):159-63. PubMed ID: 7644355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.